Filing Details
- Accession Number:
- 0001209191-19-061059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-17 21:23:21
- Reporting Period:
- 2019-12-13
- Accepted Time:
- 2019-12-17 21:23:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1708493 | Harpoon Therapeutics Inc. | HARP | Biological Products, (No Disgnostic Substances) (2836) | 473458693 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1734389 | Mark Chin | C/O Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA 94080 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-13 | 11,002 | $17.21 | 2,597,915 | No | 4 | S | Indirect | By Arix Bioscience Holdings Limited |
| Common Stock | Disposition | 2019-12-16 | 13,080 | $17.02 | 2,584,835 | No | 4 | S | Indirect | By Arix Bioscience Holdings Limited |
| Common Stock | Disposition | 2019-12-17 | 12,476 | $16.83 | 2,572,359 | No | 4 | S | Indirect | By Arix Bioscience Holdings Limited |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Arix Bioscience Holdings Limited |
| No | 4 | S | Indirect | By Arix Bioscience Holdings Limited |
| No | 4 | S | Indirect | By Arix Bioscience Holdings Limited |
Footnotes
- Represents the weighted average sales price per share. The shares sold at prices ranging from $17.00 to $17.68 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The Reporting Person is an Investment Director for Arix Bioscience plc, the parent company of Arix Bioscience Holdings Limited.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $17.00 to $17.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $16.80 to $17.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
